Generation of adenosine tri-phosphate in Leishmania donovani amastigote forms
- 175 Downloads
Leishmania, the causative agent of various forms of leishmaniasis, is the significant cause of morbidity and mortality. Regarding energy metabolism, which is an essential factor for the survival, parasites adapt to the environment under low oxygen tension in the host using metabolic systems which are very different from that of the host mammals. We carried out the study of susceptibilities to different inhibitors of mitochondrial electron transport chain and studies on substrate level phosphorylation in wild-type L. donovani. The amastigote forms of L. donovani are independent on oxidative phosphorylation for ATP production. Indeed, its cell growth was not inhibited by excess oligomycin and dicyclohexylcarbodiimide, which are the most specific inhibitors of the mitochondrial Fo/F1-ATP synthase. In contrast, mitochondrial complex I inhibitor rotenone and complex III inhibitor antimycin A inhibited amastigote cell growth, suggesting the role of complex I and complex III in cell survival. Complex II appeared to have no role in cell survival. To further investigate the site of ATP production, we studied the substrate level phosphorylation, which was involved in the synthesis of ATP. Succinate-pyruvate couple showed the highest substrate level phosphorylation in amastigotes whereas NADH-fumarate and NADH-pyruvate couples failed to produce ATP. In contrast, NADPH-fumarate showed the highest rate of ATP formation in promastigotes. Therefore, we can conclude that substrate level phosphorylation is essential for the survival of amastigote forms of Leishmania donovani.
KeywordsATP Leishmania amastigote promastigote substrate level phosphorylation oligomycin
Unable to display preview. Download preview PDF.
- Barak E., Amin-Spector S., Gerliak E., Goyard S., Holland N., Zilberstein D. 2005. Differentiation of Leishmania donovani in host free system: analysis of signal perception and response. Molecular and Biochemical Parasitology, 141, 99–108. DOI: 10.1016/j.molbiopara.2005.02.004.PubMedCrossRefGoogle Scholar
- Coustou V., Bisteiro S., Brian M., Diolez P., Bouchaud V., Voisin P., Michels P.A.M., Canioni P., Beltz T., Bringaud F. 2003. ATP generation in the Trypanosoma brucei procyclic form: Cytosolic substrate level phosphorylation is essential, but not oxidative phosphorylation. Journal of Biological Chemistry, 278, 49625–49635. DOI 10.1074/jbc.M307872200.PubMedCrossRefGoogle Scholar
- Peters W., Trotter E.R., Robinson B.L. 1980. The experimental chemotherapy of leishmaniasis, VII. Drug responses of L. major and L. mexicana amazonensis, with an analysis of promising chemical leads to new antileishmanial agents. Annals of Tropical Medicine and Parasitology, 74, 321–335.PubMedGoogle Scholar
- Rivas L., Chang L.P. 1983. Intraparasitophorous vacuolar pH of Leishmania mexicana infected macrophages. Biological Bulletin, 165, 536–537.Google Scholar
- Saar Y., Ransfold A., Waldman E., Mazareb S., Amin-Spector S., Plumblee J., Turco S.J., Zilberstein D. 1998. Characterization of developmentally regulated activities in axenic amastigotes of Leishmania donovani. Molecular and Biochemical Parasitology, 95, 9–20. DOI: 10.1016/S0166-6851(98)00062-0.PubMedCrossRefGoogle Scholar
- Singh A.K., Mukhopadhyay C., Biswas S., Singh V.K., Mukhopadhyay C.K. 2012. Intracellular pathogen Leishmania donovani activates hypoxia inducible factor-1 by dual mechanism for survival advantage within macrophage. Plos One, 7, e38489. DOI: 10.1371/journal.pone.0038489.PubMedCentralPubMedCrossRefGoogle Scholar